Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04309409
Title Adjuvant Nivolumab Treatment in Stage II (IIA, IIB, IIC) High-risk Melanoma (NivoMela)
Acronym NivoMela
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors University Hospital, Essen
Indications
Therapies
Age Groups: senior | adult
Covered Countries DEU


No variant requirements are available.